Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases

NCT04923542 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Brain Metastases
HR+ Metastatic Breast Cancer

Interventions

RADIATION: Stereotactic Radiosurgery (SRS)
DRUG: Abemaciclib
DRUG: Endocrine therapy

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]